Susquehanna International Group’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.26M | Buy |
1,489,672
+800,976
| +116% | +$1.75M | ﹤0.01% | 1744 |
|
2025
Q1 | $744K | Buy |
+688,696
| New | +$744K | ﹤0.01% | 3790 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 6759 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 6459 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 6510 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 6502 |
|
2023
Q4 | – | Sell |
-70,446
| Closed | -$116K | – | 6574 |
|
2023
Q3 | $116K | Buy |
70,446
+54,984
| +356% | +$90.2K | ﹤0.01% | 4860 |
|
2023
Q2 | $24.3K | Buy |
+15,462
| New | +$24.3K | ﹤0.01% | 5336 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 6643 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 6667 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 6828 |
|
2022
Q2 | – | Sell |
-101,554
| Closed | -$678K | – | 6591 |
|
2022
Q1 | $678K | Buy |
101,554
+8,091
| +9% | +$54K | ﹤0.01% | 3324 |
|
2021
Q4 | $517K | Sell |
93,463
-19,403
| -17% | -$107K | ﹤0.01% | 3755 |
|
2021
Q3 | $1.03M | Sell |
112,866
-125,962
| -53% | -$1.15M | ﹤0.01% | 2718 |
|
2021
Q2 | $2.65M | Buy |
238,828
+71,425
| +43% | +$793K | ﹤0.01% | 1795 |
|
2021
Q1 | $1.43M | Buy |
+167,403
| New | +$1.43M | ﹤0.01% | 2522 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 5258 |
|
2020
Q3 | – | Sell |
-10,778
| Closed | -$32K | – | 4929 |
|
2020
Q2 | $32K | Buy |
+10,778
| New | +$32K | ﹤0.01% | 4084 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 4368 |
|
2018
Q4 | – | Sell |
-217
| Closed | -$13K | – | 4742 |
|
2018
Q3 | $13K | Buy |
+217
| New | +$13K | ﹤0.01% | 3209 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 4594 |
|
2018
Q1 | – | Sell |
-34
| Closed | -$13K | – | 4405 |
|
2017
Q4 | $13K | Buy |
+34
| New | +$13K | ﹤0.01% | 3566 |
|
2017
Q3 | – | Sell |
-13
| Closed | -$12K | – | 4103 |
|
2017
Q2 | $12K | Sell |
13
-1
| -7% | -$923 | ﹤0.01% | 3427 |
|
2017
Q1 | $13K | Sell |
14
-21
| -60% | -$19.5K | ﹤0.01% | 3143 |
|
2016
Q4 | $101K | Buy |
+35
| New | +$101K | ﹤0.01% | 3895 |
|